Freedom Capital Markets Maintains Hold on AtriCure, Maintains $57 Price Target
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Freedom Capital Markets analyst Keith Hinton maintains AtriCure (NASDAQ:ATRC) with a Hold and maintains $57 price target.
Freedom Capital Markets analyst Keith Hinton maintains AtriCure (NASDAQ:ATRC) with a Hold and maintains $57 price target.
